SeeMe: Using Automated Facial Tracking to Detect Voluntary Behavior in Brain Injury
Key facts
- Who runs it
- Stony Brook University
- Where
- Stony Brook, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 80 people, planned
- Started
- 30 Mar 2026
- Expected to end
- Dec 2029
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- SeeMe Multimodal Auditory Command Protocol
- Record updated
- 5 May 2026
Who can take part
- Age
- 22 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 34 criteriaShow less
Who can take part
- Adults (22+) with a history of acute traumatic brain injury
- Documented loss of consciousness with a Glasgow Coma Scale (GCS) score less than or equal to 8 upon hospitalization
- Clinically stable as determined by the primary neurosurgery or ICU team
- Intact auditory pathways as confirmed by BAERs
- Family consent for study participation
- Adults 22+ with no history of neurological or psychiatric disorders
- Normal baseline neurological examination
- Intact auditory pathways
- Ability to provide informed consent
- Ability to follow simple auditory commands in English
- Adults (22+) undergoing elective spine surgery
- Requirement of general anesthesia and pharmacological paralysis (neuromuscular blockade) as part of the standard surgical procedure
- Clinically stable for study procedures as determined by the anesthesia and surgical teams
- Intact auditory pathways
- Ability to provide informed pre-operative consent
Who cannot take part
- Any previous history of traumatic brain injury
- Any previous history of severe traumatic brain injury (TBI)
- Any previous history of severe traumatic brain injury
- Significant baseline facial or hand motor deficits prior to the administration of anesthesia
- Hearing Impairment confirmed via absence of Brainstem Auditory Evoked Responses (BAERs) that would prevent the patient from hearing the auditory commands
- Any other medical condition that, in the judgment of the investigator, makes participation in the study unsafe
- Any neurodegenerative disease such as dementia; Group 2: Healthy Control Cohort
- Hearing Impairment that would prevent the participant from hearing the auditory commands
- Any neurodegenerative disease (e.g., dementia)
- Any motor impairment (e.g., facial palsy, carpal tunnel syndrome) that would interfere with facial or hand movement tracking
- Any other medical condition that, in the judgment of the investigator, makes participation in the study unsafe
- Hearing Impairment that would prevent the patient from hearing the auditory commands
- Any neurodegenerative disease such as dementia
- Any other medical condition that, in the judgment of the investigator, makes participation in the study unsafe
- No legal authorized representative (LAR) available to provide informed consent for the patients in a comatose state
- Pregnant women
- Pregnant women; Group 3: Sedated/Anesthetized Cohort
- Pregnant women
Other criteria
- Group 1: Traumatic Brain Injury (TBI) Cohort
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 22 and 85 years old?
Where in United States
- Stony Brook University HospitalStony Brook, United StatesContact: Sima Mofakham, PhDTaking people
About the trial
What the trial wants to find out
Objective: This prospective interventional study introduces "SeeMe," an automated, high-resolution computer vision platform designed to objectively quantify microscopic, auditory command-evoked movements in patients with Traumatic Brain Injury (TBI). Current clinical assessments, such as the Glasgow Coma Scale (GCS) and Coma Recovery Scale-Revised (CRS-R), rely on subjective human observation and often fail to detect low-amplitude motor responses, potentially misclassifying up to 25% of patients as unresponsive.
Read full original descriptionShow less
Methodology: SeeMe utilizes vector analysis, cross-correlation, and deep neural networks (DNNs) to track individual facial pores and hand movements with sub-millimeter precision (0.5 mm) and high temporal resolution (0.03s). The study will enroll a cohort of 60-80 TBI patients, alongside healthy controls and pharmacologically paralyzed subjects, to validate SeeMe's sensitivity and specificity.
Primary Goals:
1. Validation: Compare SeeMe's detection of voluntary motor recovery against gold-standard clinical examinations (CRS-R). 2. Synchronization: Simultaneously record and time-lock electroencephalography (EEG) and electrocorticography (ECoG) with SeeMe-detected movements. 3. Biomarker Identification: Characterize neural signatures (specifically Beta-band oscillations) associated with the return of voluntary behavior.
Impact: By providing a real-time, objective measure of motor intention and execution, SeeMe aims to identify "Cognitive-Motor Dissociation" (CMD) earlier than current methods, facilitating more accurate prognostications and laying the framework for future closed-loop neuromodulation (e.g., Vagus Nerve Stimulation) to accelerate TBI recovery.
The 3 groups in the trial
- TBI PatientsTreatment being tested
Patients with Traumatic Brain Injury receiving the SeeMe Auditory Stimulation protocol daily to detect covert motor responses
Treatment: SeeMe Multimodal Auditory Command Protocol
- Healthy Control CohortExisting treatment, for comparison
Awake, healthy volunteers receiving the SeeMe protocol to establish "ground truth" for normal voluntary motor signatures and algorithm sensitivity.
Treatment: SeeMe Multimodal Auditory Command Protocol
- Sedated/Paralyzed PatientsSham treatment, for comparison
Patients undergoing general anesthesia and pharmacological paralysis receiving the SeeMe protocol to establish the algorithm's specificity and "noise floor."
Treatment: SeeMe Multimodal Auditory Command Protocol
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- SeeMe: A Multimodal Behavioral-Electrophysiological Tool for Real-Time Detection of Motor Behavior in Brain Injury Patients
- Fit questions
- Built from NCT07560631, who can take part
- Record updated
- 5 May 2026